Bipolar Disorder Therapeutics Global Market Report 2025

Global Bipolar Disorder Therapeutics Market Report 2024

Bipolar Disorder Therapeutics Global Market Report 2025 – By Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs), By Mechanism (Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

Name: Bipolar Disorder Therapeutics Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Bipolar Disorder Therapeutics Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Bipolar Disorder Therapeutics Global Market Report 2024

Proud Members Of

Bipolar Disorder Therapeutics Market Definition

Bipolar disorder therapeutics refer to medication, including mood stabilizers, antidepressants, antipsychotics, and psychological counseling, to control symptoms. The bipolar disorder therapeutic is used in the treatment and management of bipolar disorders.

The main types of drugs in bipolar disorder therapeutics are mood stabilizers, antipsychotic drugs, antidepressant drugs, and other drugs. Mood stabilizers refer to a class of medications used in the management and treatment of bipolar disorders. The different mechanisms include selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines, beta-blockers, and others. These are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Bipolar Disorder Therapeutics Market Segmentation

The bipolar disorder therapeutics market covered in this report is segmented –

1) By Drug Class: Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs

2) By Mechanism: Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Mood Stabilizers: lithium, Anticonvulsants, Calcium Channel Blockers

2) By Antipsychotic Drugs: Atypical Antipsychotics, Typical Antipsychotics

3) By Antidepressant Drugs: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs)

4) By Other Drugs: Benzodiazepines, Adjunctive Therapies, Herbal Supplements

Bipolar Disorder Therapeutics Market Size and growth rate 2025 to 2029: Graph

Bipolar Disorder Therapeutics Market Size 2025 And Growth Rate

The bipolar disorder therapeutics market size has grown strongly in recent years. It will grow from $7.44 billion in 2024 to $7.89 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rise in medical research and developments, increased healthcare expenditure, rise in prevalence of mental health disorders, rise in patient advocacy.

Bipolar Disorder Therapeutics Market Growth Forecast

The bipolar disorder therapeutics market size is expected to see strong growth in the next few years. It will grow to $9.98 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing prevalence of bipolar disorder, government initiatives, expansion of healthcare infrastructure, growing adoption of a sedentary lifestyle. Major trends in the forecast period include personalized treatment approaches, digital health integration, innovative medications, preventive interventions, neuroimaging and biomarkers.

Book your 30 minutes free consultation with our research experts

Bipolar Disorder Therapeutics Market Driver: A Lifelong Condition That Requires Early Diagnosis And Proper Treatment

The increasing healthcare expenditure is expected to propel the growth of the bipolar disorder therapeutics market going forward. Healthcare infrastructure refers to all costs or outlays for medical care, preventative measures, public health initiatives, rehabilitation, community health activities, and health research. Increasing healthcare expenditure can be attributed to several factors, including an aging population, a rise in chronic diseases, and higher drug costs, all of which significantly contribute to the growing demand for medical services and treatments. As awareness of mental health issues rises, the diagnosis of bipolar disorder increases, leading to a higher demand for therapeutic interventions. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health spending in Canada is anticipated to rise by 2.8% in 2023, following a modest growth of just 1.5% in 2022. Therefore, the increasing healthcare expenditure is driving the growth of the bipolar disorder therapeutics market.

Bipolar Disorder Therapeutics Market Driver: Increasing Demand For Psychological Counseling Drives Growth Of Bipolar Disorder Therapeutics Market

Increasing demand for psychological counseling is expected to propel the growth of the bipolar disorder therapeutics market going forward. One sort of therapy that tries to assist people in overcoming mental health issues and enhancing their quality of life is psychological counselling. Psychotherapy can assist in managing bipolar illness symptoms and determining the factors that set off bipolar episodes. It can also assist people in learning useful coping mechanisms for stressful situations. For instance, in September 2022, according to The Centers for Disease Control and Prevention (CDC), the percentages of men (from 13.1% to 17.8%) and women (from 23.8% to 28.6%) aged 18–44 who had received any mental health treatment in the past 12 months increased in the U.S. Therefore, increased psychological counselling demand drives the bipolar disorder therapeutics market.

Global Bipolar Disorder Therapeutics Market Major Players

Major companies operating in the bipolar disorder therapeutics market include AbbVie Inc., Pfizer Inc., Astellas Pharma Inc, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Januaryssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Validus Pharmaceuticals, Eli Lilly and Company, Gedeon Richter PLC., Sumitomo Pharma Co. Ltd, H. Lundbeck A/S, Janssen Pharmaceuticals, Sanofi S.A., Lundbeck A/S, Allergan plc, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes plc, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Celon Pharma SA, NeuroRx Inc., IntraCellular Therapies Inc., Sumitomo Pharma Co. Ltd., Vanda Pharmaceuticals Inc., Sage Therapeutics Inc.

Global Bipolar Disorder Therapeutics Market Trend: Strategic Partnerships Driving Growth In The Bipolar Disorder Therapeutics Market

Strategic partnerships have emerged as a key trend gaining popularity in the bipolar disorder therapeutics market. Major companies operating in the bipolar disorder therapeutics sector are focused on partnerships to reinforce their position. For instance, in April 2022, BioXcel Therapeutics, Inc., a US-based biopharmaceutical company, approved IGALMITM (dexmedetomidine), a specifically FDA-approved sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. that dissolves in the mouth, specifically formulated for addressing mild, moderate, or severe agitation in these patient groups. The drug is designed for a rapid onset of action, enabling effective management of agitation episodes.

Global Bipolar Disorder Therapeutics Market Trend: The Rise Of Novel Therapies For Bipolar Disorders

Major companies operating in the Bipolar Disorder Therapeutics and related market are developing new treatment for depressive episodes associated with bipolar I or II disorder to meet larger customer bases, more sales, and increase revenue. Among bipolar disorders, bipolar depression is the most prevalent and severe clinical manifestation. If compared to manic/hypomanic episodes, these depressed episodes are linked to a poorer prognosis, longer duration, and more recurrences. For instance, in March 2024, the EDIT-B consortium, a France-based collaborative organization that specializes in developing innovative diagnostic tools and biomarkers, launched myEDIT-B, an innovative blood diagnostic tool designed to provide objective biological data that aids psychiatrists and healthcare professionals in making precise diagnoses. It analyzes RNA editing-based biomarkers and has demonstrated sensitivity and specificity rates above 80%. By facilitating quicker and more accurate diagnoses—potentially shortening the wait time to within four weeks—myEDIT-B aims to tackle the significant issue of misdiagnosis in mental health, with around 40% of individuals diagnosed with depression possibly having bipolar disorder instead.

Bipolar Disorder Therapeutics Market Merger And Acquisition: Neuraxpharm's Expansion With Lazap® In Europe

In June 2023, Brain Therapeutics, a Greece-based central nervous system specialty company, acquired the prescription drug brand Lazap (olanzapine) from the Greek pharmaceutical company Lyofin Ltd for an undisclosed amount. The acquisition enables Neuraxpharm Group to expand its therapeutic product portfolio in Greece and Europe. This agreement aims to extend Neuraxpharm's reach in Greece and harness its deep expertise in the central nervous system (CNS) to offer the right products from its extensive lineup to CNS patients, healthcare professionals, pharmacists, and hospitals across Greece, effectively meeting the healthcare demands of patients in the country. Lyofin Ltd. is a Greece-based pharmaceutical company.

Regional Outlook For The Global Bipolar Disorder Therapeutics Market

North America was the largest region in the bipolar disorder therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bipolar disorder therapeutics market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Bipolar Disorder Therapeutics Market?

The bipolar disorder therapeutics market includes revenues earned by entities by family-focused therapy, interpersonal and social rhythm therapy, cognitive behavioral therapy and dialectical behavior therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Bipolar Disorder Therapeutics Industry?

The bipolar disorder therapeutics market research report is one of a series of new reports from The Business Research Company that provides bipolar disorder therapeutics market statistics, including bipolar disorder therapeutics industry global market size, regional shares, competitors with a bipolar disorder therapeutics market share, detailed bipolar disorder therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the bipolar disorder therapeutics industry. This bipolar disorder therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bipolar Disorder Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$7.89 billion
Revenue Forecast In 2034	$9.98 billion
Growth Rate	CAGR of 6.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Drug Class: Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs 2) By Mechanism: Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments: 1) By Mood Stabilizers: Lithium, Anticonvulsants, Calcium Channel Blockers 2) By Antipsychotic Drugs: Atypical Antipsychotics, Typical Antipsychotics 3) By Antidepressant Drugs: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs) 4) By Other Drugs: Benzodiazepines, Adjunctive Therapies, Herbal Supplements
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	AbbVie Inc., Pfizer Inc., Astellas Pharma Inc, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC, Januaryssen Pharmaceuticals, Novartis AG, Otsuka Pharmaceutical Co. Ltd., Validus Pharmaceuticals, Eli Lilly and Company, Gedeon Richter PLC., Sumitomo Pharma Co. Ltd, H. Lundbeck A/S, Janssen Pharmaceuticals, Sanofi S.A., Lundbeck A/S, Allergan plc, Takeda Pharmaceutical Company Limited, Sunovion Pharmaceuticals Inc., Alkermes plc, Mylan N.V., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Celon Pharma SA, NeuroRx Inc., IntraCellular Therapies Inc., Sumitomo Pharma Co. Ltd., Vanda Pharmaceuticals Inc., Sage Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Bipolar Disorder Therapeutics Market Characteristics

3. Bipolar Disorder Therapeutics Market Trends And Strategies

4. Bipolar Disorder Therapeutics Market- Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bipolar Disorder Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Bipolar Disorder Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Bipolar Disorder Therapeutics Market Growth Rate Analysis

5.4. Global Bipolar Disorder Therapeutics Historic Market Size and Growth, 2019- 2024, Value ($ Billion)

5.5. Global Bipolar Disorder Therapeutics Forecast Market Size and Growth, 2024- 2029, 2034F, Value ($ Billion)

5.6. Global Bipolar Disorder Therapeutics Total Addressable Market (TAM)

6. Bipolar Disorder Therapeutics Market Segmentation

6.1. Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mood Stabilizers

Antipsychotic Drugs

Antidepressant Drugs

Other Drugs

6.2. Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Selective Serotonin Reuptake Inhibitors

Serotonin-norepinephrine Reuptake Inhibitors

Tricyclic Antidepressants

Monoamine Oxidase Inhibitors

Benzodiazepines

Beta-Blockers

Other Mechanisms

6.3. Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

6.4. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Mood Stabilizers, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lithium

Anticonvulsants

Calcium Channel Blockers

6.5. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antipsychotic Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Atypical Antipsychotics

Typical Antipsychotics

6.6. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antidepressant Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Selective Serotonin Reuptake Inhibitors (SSRIs)

Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)

Tricyclic Antidepressants (TCAs)

6.7. Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Other Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Benzodiazepines

Adjunctive Therapies

Herbal Supplements

7. Bipolar Disorder Therapeutics Market Regional And Country Analysis

7.1. Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bipolar Disorder Therapeutics Market

8.1. Asia-Pacific Bipolar Disorder Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bipolar Disorder Therapeutics Market

9.1. China Bipolar Disorder Therapeutics Market Overview

9.2. China Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bipolar Disorder Therapeutics Market

10.1. India Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bipolar Disorder Therapeutics Market

11.1. Japan Bipolar Disorder Therapeutics Market Overview

11.2. Japan Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bipolar Disorder Therapeutics Market

12.1. Australia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bipolar Disorder Therapeutics Market

13.1. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bipolar Disorder Therapeutics Market

14.1. South Korea Bipolar Disorder Therapeutics Market Overview

14.2. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bipolar Disorder Therapeutics Market

15.1. Western Europe Bipolar Disorder Therapeutics Market Overview

15.2. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bipolar Disorder Therapeutics Market

16.1. UK Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bipolar Disorder Therapeutics Market

17.1. Germany Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bipolar Disorder Therapeutics Market

18.1. France Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bipolar Disorder Therapeutics Market

19.1. Italy Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bipolar Disorder Therapeutics Market

20.1. Spain Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bipolar Disorder Therapeutics Market

21.1. Eastern Europe Bipolar Disorder Therapeutics Market Overview

21.2. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bipolar Disorder Therapeutics Market

22.1. Russia Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bipolar Disorder Therapeutics Market

23.1. North America Bipolar Disorder Therapeutics Market Overview

23.2. North America Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bipolar Disorder Therapeutics Market

24.1. USA Bipolar Disorder Therapeutics Market Overview

24.2. USA Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bipolar Disorder Therapeutics Market

25.1. Canada Bipolar Disorder Therapeutics Market Overview

25.2. Canada Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bipolar Disorder Therapeutics Market

26.1. South America Bipolar Disorder Therapeutics Market Overview

26.2. South America Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bipolar Disorder Therapeutics Market

27.1. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bipolar Disorder Therapeutics Market

28.1. Middle East Bipolar Disorder Therapeutics Market Overview

28.2. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bipolar Disorder Therapeutics Market

29.1. Africa Bipolar Disorder Therapeutics Market Overview

29.2. Africa Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bipolar Disorder Therapeutics Market Competitive Landscape And Company Profiles

30.1. Bipolar Disorder Therapeutics Market Competitive Landscape

30.2. Bipolar Disorder Therapeutics Market Company Profiles

30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Astellas Pharma Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

31. Bipolar Disorder Therapeutics Market Other Major And Innovative Companies

31.1. GlaxoSmithKline PLC

31.2. Januaryssen Pharmaceuticals

31.3. Novartis AG

31.4. Otsuka Pharmaceutical Co. Ltd.

31.5. Validus Pharmaceuticals

31.6. Eli Lilly and Company

31.7. Gedeon Richter PLC.

31.8. Sumitomo Pharma Co. Ltd

31.9. H. Lundbeck A/S

31.10. Janssen Pharmaceuticals

31.11. Sanofi S.A.

31.12. Lundbeck A/S

31.13. Allergan plc

31.14. Takeda Pharmaceutical Company Limited

31.15. Sunovion Pharmaceuticals Inc.

32. Global Bipolar Disorder Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bipolar Disorder Therapeutics Market

34. Recent Developments In The Bipolar Disorder Therapeutics Market

35. Bipolar Disorder Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Bipolar Disorder Therapeutics Market In 2029- Countries Offering Most New Opportunities

35.2 Bipolar Disorder Therapeutics Market In 2029- Segments Offering Most New Opportunities

35.3 Bipolar Disorder Therapeutics Market In 2029- Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Mood Stabilizers, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antipsychotic Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antidepressant Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Other Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: AbbVie Inc. Financial Performance

Table 79: Pfizer Inc. Financial Performance

Table 80: Astellas Pharma Inc Financial Performance

Table 81: AstraZeneca PLC Financial Performance

Table 82: Bristol-Myers Squibb Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Mood Stabilizers, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antipsychotic Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Antidepressant Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Bipolar Disorder Therapeutics Market, Sub-Segmentation Of Other Drugs, By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Bipolar Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Bipolar Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Mechanism, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Bipolar Disorder Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: AbbVie Inc. Financial Performance

Figure 79: Pfizer Inc. Financial Performance

Figure 80: Astellas Pharma Inc Financial Performance

Figure 81: AstraZeneca PLC Financial Performance

Figure 82: Bristol-Myers Squibb Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

Healthcare Personal Protective Equipment Global Market Report 2025 – By Product (Head, Eye & Face Protection, Hearing Protection, Protective Clothing, Respiratory Protection, Protective Footwear, Fall Protection, Hand Protection), By Usability (Disposable, Reusable), By End Use (Hospitals And Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Diagnostic Laboratories, Other End Uses) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare Reimbursement Global Market Report 2025 – By Claims (Underpaid, Full Paid), By Payers (Private Payers, Public Payers), By Service Provider (Physician Office, Hospitals, Diagnostic Laboratories, Other Service Providers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare Services Global Market Report 2025 – By Type (Medical And Diagnostic Laboratory Services, Dental Services, Home Health Care And Residential Nursing Care Services, Residential Substance Abuse And Mental Health Facilities, Hospitals And Outpatient Care Centers, Physicians And Other Health Practitioners, All Other Ambulatory Health Care Services, Ambulance Services), By End User Gender (Male, Female), By Type of Expenditure (Public, Private) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare Nanotechnology Global Market Report 2025 – By Disease (Cardiovascular Diseases, Oncological Diseases, Neurological Diseases, Orthopedic Diseases, Infectious Diseases), By Type (Organic, Inorganic, Carbon-Based), By Application (Drug Delivery, Biomaterials, Active Implants, Tissue Regeneration) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare/Medical Simulation Global Market Report 2025 – By Product And Service (Healthcare Anatomical Models, Web-Based Simulation, Healthcare Simulation Software, Simulation Training Services), By End-User (Academic Institutes, Hospitals, Military Organizations, Other End-Users), By Technology (High-Fidelity Simulators, Medium-Fidelity Simulators, Low-Fidelity Simulators) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare RFID Global Market Report 2025 – By Product (Tags and Labels, RFID Systems), By End-User (Hospitals, Pharmaceuticals, Research Institutions and Laboratories, Other End Users), By Application (Asset Tracking, Patient Tracking, Pharmaceutical Tracking, Blood Tracking, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare BPO Global Market Report 2025 – By Provider Service (Revenue Cycle Management, Patient Enrollment And Strategic Planning, Patient Care), By Payer Service (Human Resource Management, Claims Management, Customer Relationship Management (CRM), Operational/Administrative Management, Care Management, Provider Management, Other Payer Services), By Pharmaceutical Service (Research And Development, Manufacturing, Non-clinical Service) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Healthcare Interoperability Solutions Global Market Report 2025 – By Type (Software Solutions, Services), By Software Solutions (Electronic Health Record (EHR) Interoperability Solutions, Lab System Interoperability Solutions, Imaging System Interoperability Solutions, Healthcare Information Exchange Interoperability Solutions, Enterprise Interoperability Solutions, Other Healthcare Interoperability Solutions), By Level of Interoperability (Foundational Interoperability, Structural Interoperability, Semantic Interoperability), By End User (Healthcare Providers, Healthcare Payers, Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the bipolar disorder therapeutics market?

How will the bipolar disorder therapeutics market drivers and restraints affect the bipolar disorder therapeutics market dynamics? What forces will shape the bipolar disorder therapeutics industry going forward?

The bipolar disorder therapeutics market major growth driver - A Lifelong Condition That Requires Early Diagnosis And Proper Treatment. For further insights on the bipolar disorder therapeutics market, request a sample here

What is the forecast market size or the forecast market value of the bipolar disorder therapeutics market?

The bipolar disorder therapeutics market size has grown strongly in recent years. It will grow from $7.44 billion in 2024 to $7.89 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to rise in medical research and developments, increased healthcare expenditure, rise in prevalence of mental health disorders, rise in patient advocacy. The bipolar disorder therapeutics market size is expected to see strong growth in the next few years. It will grow to $9.98 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to increasing prevalence of bipolar disorder, government initiatives, expansion of healthcare infrastructure, growing adoption of a sedentary lifestyle. Major trends in the forecast period include personalized treatment approaches, digital health integration, innovative medications, preventive interventions, neuroimaging and biomarkers. For further insights on the bipolar disorder therapeutics market, request a sample here

How is the bipolar disorder therapeutics market segmented?

The bipolar disorder therapeutics market is segmented
1) By Drug Class: Mood Stabilizers, Antipsychotic Drugs, Antidepressant Drugs, Other Drugs
2) By Mechanism: Selective Serotonin Reuptake Inhibitors, Serotonin-norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines, Beta-Blockers, Other Mechanisms
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments:
1) By Mood Stabilizers: Lithium, Anticonvulsants, Calcium Channel Blockers
2) By Antipsychotic Drugs: Atypical Antipsychotics, Typical Antipsychotics
3) By Antidepressant Drugs: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Tricyclic Antidepressants (TCAs)
4) By Other Drugs: Benzodiazepines, Adjunctive Therapies, Herbal Supplements For further insights on the bipolar disorder therapeutics market, request a sample here

Which region has the largest share of the bipolar disorder therapeutics market? What are the other regions covered in the report?

North America was the largest region in the bipolar disorder therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the bipolar disorder therapeutics market, request a sample here.

Who are the major players in the bipolar disorder therapeutics market?

What are the key trends in the bipolar disorder therapeutics market?

Major trend in the bipolar disorder therapeutics market - Strategic Partnerships Driving Growth In The Bipolar Disorder Therapeutics Market. For further insights on the bipolar disorder therapeutics market, request a sample here.

What are the major opportunities in the bipolar disorder therapeutics market? What are the strategies for the bipolar disorder therapeutics market?

For detailed insights on the major opportunities and strategies in the bipolar disorder therapeutics market, request a sample here.

How does the bipolar disorder therapeutics market relate to the overall economy and other similar markets?

For detailed insights on bipolar disorder therapeutics market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the bipolar disorder therapeutics industry?

For detailed insights on the mergers and acquisitions in the bipolar disorder therapeutics industry, request a sample here.

What are the key dynamics influencing the bipolar disorder therapeutics market growth? SWOT analysis of the bipolar disorder therapeutics market.

For detailed insights on the key dynamics influencing the bipolar disorder therapeutics market growth and SWOT analysis of the bipolar disorder therapeutics industry, request a sample here.